Edgewise Therapeutics reported total assets of $479.69M and total liabilities of $31.61M for the quarter ended Jun 2026, down 21.8% year over year. This balance sheet covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.62M | 0.70M | 0.79M | 0.88M | 0.98M | 1.06M | 1.26M | 1.68M | 2.13M | 2.62M | 3.09M | 3.57M | 4.11M | 4.68M | 5.20M | 5.72M | 6.24M | 6.77M | 7.31M | 7.85M | ||||||
| Assets | ||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 290.50M | 15.57M | 265.80M | 248.40M | 364.80M | 21.99M | 328.00M | 309.90M | 289.70M | 86.10M | 532.80M | 511.80M | 492.50M | 41.67M | 436.40M | 594.00M | 563.30M | 61.15M | 499.60M | 460.70M | ||||||
| Prepaid Assets | 2.76M | 2.98M | 2.78M | 4.95M | 5.32M | 5.05M | 5.41M | 7.07M | 8.22M | 8.60M | 8.67M | 7.69M | 6.90M | 5.31M | 6.79M | 9.26M | 10.56M | 13.28M | 10.23M | 6.45M | ||||||
| Current Assets | 293.24M | 283.77M | 268.62M | 253.34M | 370.14M | 357.00M | 333.36M | 317.00M | 297.92M | 327.00M | 541.43M | 519.44M | 499.44M | 475.48M | 443.18M | 603.25M | 573.90M | 543.38M | 509.79M | 471.52M | ||||||
| Non-Current Assets | ||||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.91M | 0.91M | 1.44M | 2.04M | 5.43M | 8.53M | 10.40M | 10.86M | 10.68M | 10.44M | 10.18M | 9.90M | 9.97M | 9.50M | 8.99M | 8.60M | 8.13M | 7.83M | 7.40M | 6.89M | ||||||
| Other Non-Current Assets | 0.29M | 0.55M | 0.56M | 0.45M | 0.26M | 0.25M | 0.25M | 0.42M | 0.47M | 0.35M | 0.26M | 0.26M | 0.26M | 0.69M | 4.36M | |||||||||||
| Non-Current Assets | 1.21M | 1.46M | 4.13M | 4.06M | 7.01M | 10.10M | 13.04M | 13.63M | 13.44M | 13.04M | 12.38M | 12.21M | 11.85M | 11.33M | 11.21M | 10.08M | 9.57M | 9.22M | 8.73M | 8.17M | ||||||
| Assets | 294.45M | 285.23M | 272.75M | 257.40M | 377.15M | 367.10M | 346.40M | 330.62M | 311.36M | 340.04M | 553.81M | 531.65M | 511.28M | 486.82M | 454.39M | 613.33M | 583.47M | 552.60M | 518.52M | 479.69M | ||||||
| Liabilities | ||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||
| Accounts Payables | 2.29M | 3.84M | 5.34M | 2.83M | 5.76M | 6.11M | 3.88M | 3.78M | 5.32M | 4.03M | 4.72M | 6.80M | 5.65M | 5.58M | 8.79M | 8.32M | 6.16M | 6.01M | 7.29M | 4.67M | ||||||
| Notes Payables | 0.01M | |||||||||||||||||||||||||
| Payables | 2.29M | 3.84M | 5.34M | 2.83M | 5.76M | 6.11M | 3.88M | 3.78M | 5.32M | 4.03M | 4.72M | 6.80M | 5.65M | 5.58M | 8.79M | 8.32M | 6.16M | 6.01M | 7.29M | 4.67M | ||||||
| Accumulated Expenses | 4.43M | 3.88M | 3.32M | 4.26M | 4.63M | 5.84M | 5.97M | 6.62M | 5.68M | 6.07M | 5.97M | 5.14M | 6.18M | 10.06M | 7.35M | 5.94M | 8.00M | 12.43M | 8.55M | 8.58M | ||||||
| Other Accumulated Expenses | 0.36M | 0.41M | 0.87M | 0.80M | 1.09M | 1.06M | 0.96M | 0.92M | 0.47M | 0.40M | 0.90M | 0.76M | 0.77M | 0.74M | 1.04M | 0.68M | 0.71M | 0.76M | 1.19M | 0.96M | ||||||
| Short term Debt | 0.01M | |||||||||||||||||||||||||
| Current Leases | 0.10M | 0.21M | 0.61M | 0.80M | 0.87M | 0.93M | 0.98M | 0.98M | 0.99M | 0.99M | 1.00M | 1.00M | 1.00M | 1.01M | 1.01M | 1.02M | 1.02M | |||||||||
| Total Current Liabilities | 8.75M | 10.52M | 10.00M | 9.22M | 13.30M | 16.59M | 12.71M | 14.40M | 16.34M | 16.77M | 14.60M | 17.18M | 18.96M | 23.86M | 21.11M | 20.90M | 21.65M | 27.37M | 22.54M | 29.04M | ||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||
| Non-Current Debt | 0.06M | |||||||||||||||||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||
| Liabilities from Discontinued Operations | 9.59M | |||||||||||||||||||||||||
| Operating Leases | 2.20M | 1.64M | 2.39M | 3.80M | 4.84M | 4.77M | 4.60M | 4.43M | 4.26M | 4.00M | 3.45M | 3.74M | 3.56M | 3.37M | 3.17M | 2.98M | 2.78M | 2.57M | ||||||||
| Other Non-Current Liabilities | 0.29M | 0.33M | 0.19M | 0.19M | ||||||||||||||||||||||
| Total Non-Current Liabilities | 8.75M | 10.52M | 12.20M | 10.85M | ||||||||||||||||||||||
| Total Liabilities | 9.05M | 10.85M | 12.39M | 11.04M | 15.75M | 20.39M | 17.56M | 19.17M | 20.94M | 21.20M | 18.86M | 21.17M | 22.41M | 27.60M | 24.67M | 24.26M | 24.82M | 30.35M | 25.32M | 31.61M | ||||||
| Shareholder's Equity | ||||||||||||||||||||||||||
| Total Debt | 0.07M | |||||||||||||||||||||||||
| Common Equity | 285.40M | 274.38M | 260.36M | 246.35M | 361.40M | 346.72M | 328.84M | 311.45M | 290.43M | 318.83M | 534.94M | 510.47M | 488.88M | 459.22M | 429.72M | 589.07M | 558.65M | 522.26M | 493.20M | 448.08M | ||||||
| Liabilities and Shareholders Equity | 294.45M | 285.23M | 272.75M | 257.40M | 377.15M | 367.10M | 346.40M | 330.62M | 311.36M | 340.04M | 553.81M | 531.65M | 511.28M | 486.82M | 454.39M | 613.33M | 583.47M | 552.60M | 518.52M | 479.69M | ||||||
| Retained Earnings | 349.68M | 351.85M | 353.90M | 356.37M | 488.76M | 492.67M | 496.52M | 500.90M | 505.46M | 563.49M | 809.08M | 816.30M | 826.73M | 837.36M | 848.68M | 1,044.35M | 1,054.09M | 1,067.94M | 1,088.83M | 1,101.28M | ||||||
| Treasury Shares |